The miniferritin HP-NAP of was originally described as a neutrophil-activating protein because of the capacity to activate neutrophils to generate oxygen radicals and adhere to endothelia. Currently, the main feature for which HP-NAP is known is the ability to promote Th1 responses and revert the immune suppressive profile of macrophages. In this review, we discuss the immune modulating properties of the protein regarding the infection and the evidence that support the potential clinical application of HP-NAP in allergy and cancer immunotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277015 | PMC |
| http://dx.doi.org/10.3389/fimmu.2022.944139 | DOI Listing |
Publication Analysis
Top Keywords
hp-nap
4
hp-nap power
4
power immunomodulation
4
immunomodulation miniferritin
4
miniferritin hp-nap
4
hp-nap originally
4
originally described
4
described neutrophil-activating
4
neutrophil-activating protein
4
protein capacity
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!